C50.322
BillableMalignant neoplasm of lower-inner quadrant of left male breast
HCC Category Mapping
What This Code Means
Cancer that starts in the lower-inner area of the left breast in a male patient.
Coding Tips
- •Confirm left breast laterality is documented to differentiate from C50.321
- •Document the specific quadrant location to ensure appropriate code selection
Clinical Significance
Malignant neoplasm of the lower-inner quadrant of left male breast represents invasive breast cancer requiring staging, treatment planning, and ongoing surveillance. Breast cancer is risk-adjusted because it demands significant healthcare resources including surgery, radiation, chemotherapy, hormonal therapy, and long-term monitoring. Male breast cancer accounts for less than 1% of all breast cancers, making accurate gender-specific coding particularly important for tracking and research.
Documentation Requirements
- ✓Pathologic confirmation of invasive malignancy (biopsy with histologic type — ductal, lobular, etc.)
- ✓Laterality: left breast
- ✓Gender documented as male to support gender-specific code selection
- ✓Quadrant or subsite location: lower-inner quadrant
- ✓Tumor size (T stage) and grade
- ✓Lymph node status (N stage) — axillary, sentinel node biopsy results
- ✓Estrogen receptor, progesterone receptor, and HER2 status
- ✓Stage grouping (I-IV)
- ✓Current treatment status (active treatment, hormonal therapy, surveillance)